“…Furthermore, analogue 20 has a phenyl substituent at position 6 of the six-member ring, which is not present on analogue A (Figure 1), the hapten used to construct the immunogen. Inactive analogues 7, 18, and 21 (Figure 2) are missing the critical oxime functional group at position 2 of cyclohexane ring (Markley et al, 1995;Webb et al, 1997). However, analogue 22 (Figure 2) possesses all of the critical functional groups associated with active cyclohexanedione inhibitors, namely, a cyclohexane ring with a carbonyl group at position 1, an oxyimino group at position 2, and a hydroxyl group at position 3 (Markley et al, 1995;Webb et al, 1997).…”